07:00 , Apr 14, 2016 |  BC Innovations  |  Product R&D

AACR by the numbers

See Figure: Top indications See Table: Novel cancer targets at AACR 2016 See Figure: Top institutions and companies See Figure: Top targets Tables Novel cancer targets at AACR 2016 Breast cancer amplified sequence 1 (BCAS1)...
07:00 , Aug 23, 2012 |  BC Innovations  |  Targets & Mechanisms

Broader is better

A team from the Crucell Vaccine Institute and The Scripps Research Institute has identified a trio of neutralizing human mAbs that protect mice from challenge with influenza viruses, including one mAb that protects against both...
07:00 , Mar 15, 2010 |  BC Week In Review  |  Clinical News

Celltrion preclinical data

In mice, CT120 protected against H5N1 and pandemic and seasonal H1N1 influenza viruses. The broad-spectrum mAb also exhibited a therapeutic effect in mice infected with H5N1. Celltrion Inc. , Incheon, South Korea   Product: CT120...